Cargando…
Impact of Gene Dosage on Gene Expression, Biological Processes and Survival in Cervical Cancer: A Genome-Wide Follow-Up Study
We investigated the role of tumor copy number (CN)–altered genome (CN-AG) in the carcinogenesis of cervical cancer (CC), especially its effect on gene expression, biological processes, and patient survival. Fifty-nine human papillomavirus 16 (HPV16)-positive CCs were investigated with microarrays–31...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039463/ https://www.ncbi.nlm.nih.gov/pubmed/24879114 http://dx.doi.org/10.1371/journal.pone.0097842 |
_version_ | 1782318491105230848 |
---|---|
author | Medina-Martinez, Ingrid Barrón, Valeria Roman-Bassaure, Edgar Juárez-Torres, Eligia Guardado-Estrada, Mariano Espinosa, Ana María Bermudez, Miriam Fernández, Fernando Venegas-Vega, Carlos Orozco, Lorena Zenteno, Edgar Kofman, Susana Berumen, Jaime |
author_facet | Medina-Martinez, Ingrid Barrón, Valeria Roman-Bassaure, Edgar Juárez-Torres, Eligia Guardado-Estrada, Mariano Espinosa, Ana María Bermudez, Miriam Fernández, Fernando Venegas-Vega, Carlos Orozco, Lorena Zenteno, Edgar Kofman, Susana Berumen, Jaime |
author_sort | Medina-Martinez, Ingrid |
collection | PubMed |
description | We investigated the role of tumor copy number (CN)–altered genome (CN-AG) in the carcinogenesis of cervical cancer (CC), especially its effect on gene expression, biological processes, and patient survival. Fifty-nine human papillomavirus 16 (HPV16)-positive CCs were investigated with microarrays–31 for mapping CN-AG and 55 for global gene expression, with 27 CCs in common. Five-year survival was investigated in 55 patients. Deletions and amplifications >2.5 Mb were defined as CN alterations. The %CN-AG varied from 0 to 32.2% (mean = 8.1±8.9). Tumors were classified as low (mean = 0.5±0.6, n = 11), medium (mean = 5.4±2.4, n = 10), or high (mean = 19.2±6.6, n = 10) CN. The highest %CN-AG was found in 3q, which contributed an average of 55% of all CN alterations. Genome-wide, only 5.3% of CN-altered genes were deregulated directly by gene dosage. In contrast, the rate in fully duplicated 3q was twice as high. Amplification of 3q explained 23.2% of deregulated genes in whole tumors (r(2) = 0.232, p = 0.006; analysis of variance), including genes located in 3q and other chromosomes. A total of 862 genes were deregulated exclusively in high-CN tumors, but only 22.9% were CN altered. This suggests that the remaining genes are not deregulated directly by gene dosage, but by mechanisms induced in trans by CN-altered genes. Anaphase-promoting complex/cyclosome (APC/C)-dependent proteasome proteolysis, glycolysis, and apoptosis were upregulated, whereas cell adhesion and angiogenesis were downregulated exclusively in high-CN tumors. The high %CN-AG and upregulated gene expression profile of APC/C-dependent proteasome proteolysis were associated with poor patient survival (p<0.05, log-rank test). Along with glycolysis, they were linearly associated with FIGO stage (r>0.38, p<0.01, Spearman test). Therefore, inhibition of APC/C-dependent proteasome proteolysis and glycolysis could be useful for CC treatment. However, whether they are indispensable for tumor growth remains to be demonstrated. |
format | Online Article Text |
id | pubmed-4039463 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-40394632014-06-02 Impact of Gene Dosage on Gene Expression, Biological Processes and Survival in Cervical Cancer: A Genome-Wide Follow-Up Study Medina-Martinez, Ingrid Barrón, Valeria Roman-Bassaure, Edgar Juárez-Torres, Eligia Guardado-Estrada, Mariano Espinosa, Ana María Bermudez, Miriam Fernández, Fernando Venegas-Vega, Carlos Orozco, Lorena Zenteno, Edgar Kofman, Susana Berumen, Jaime PLoS One Research Article We investigated the role of tumor copy number (CN)–altered genome (CN-AG) in the carcinogenesis of cervical cancer (CC), especially its effect on gene expression, biological processes, and patient survival. Fifty-nine human papillomavirus 16 (HPV16)-positive CCs were investigated with microarrays–31 for mapping CN-AG and 55 for global gene expression, with 27 CCs in common. Five-year survival was investigated in 55 patients. Deletions and amplifications >2.5 Mb were defined as CN alterations. The %CN-AG varied from 0 to 32.2% (mean = 8.1±8.9). Tumors were classified as low (mean = 0.5±0.6, n = 11), medium (mean = 5.4±2.4, n = 10), or high (mean = 19.2±6.6, n = 10) CN. The highest %CN-AG was found in 3q, which contributed an average of 55% of all CN alterations. Genome-wide, only 5.3% of CN-altered genes were deregulated directly by gene dosage. In contrast, the rate in fully duplicated 3q was twice as high. Amplification of 3q explained 23.2% of deregulated genes in whole tumors (r(2) = 0.232, p = 0.006; analysis of variance), including genes located in 3q and other chromosomes. A total of 862 genes were deregulated exclusively in high-CN tumors, but only 22.9% were CN altered. This suggests that the remaining genes are not deregulated directly by gene dosage, but by mechanisms induced in trans by CN-altered genes. Anaphase-promoting complex/cyclosome (APC/C)-dependent proteasome proteolysis, glycolysis, and apoptosis were upregulated, whereas cell adhesion and angiogenesis were downregulated exclusively in high-CN tumors. The high %CN-AG and upregulated gene expression profile of APC/C-dependent proteasome proteolysis were associated with poor patient survival (p<0.05, log-rank test). Along with glycolysis, they were linearly associated with FIGO stage (r>0.38, p<0.01, Spearman test). Therefore, inhibition of APC/C-dependent proteasome proteolysis and glycolysis could be useful for CC treatment. However, whether they are indispensable for tumor growth remains to be demonstrated. Public Library of Science 2014-05-30 /pmc/articles/PMC4039463/ /pubmed/24879114 http://dx.doi.org/10.1371/journal.pone.0097842 Text en © 2014 Medina-Martínez et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Medina-Martinez, Ingrid Barrón, Valeria Roman-Bassaure, Edgar Juárez-Torres, Eligia Guardado-Estrada, Mariano Espinosa, Ana María Bermudez, Miriam Fernández, Fernando Venegas-Vega, Carlos Orozco, Lorena Zenteno, Edgar Kofman, Susana Berumen, Jaime Impact of Gene Dosage on Gene Expression, Biological Processes and Survival in Cervical Cancer: A Genome-Wide Follow-Up Study |
title | Impact of Gene Dosage on Gene Expression, Biological Processes and Survival in Cervical Cancer: A Genome-Wide Follow-Up Study |
title_full | Impact of Gene Dosage on Gene Expression, Biological Processes and Survival in Cervical Cancer: A Genome-Wide Follow-Up Study |
title_fullStr | Impact of Gene Dosage on Gene Expression, Biological Processes and Survival in Cervical Cancer: A Genome-Wide Follow-Up Study |
title_full_unstemmed | Impact of Gene Dosage on Gene Expression, Biological Processes and Survival in Cervical Cancer: A Genome-Wide Follow-Up Study |
title_short | Impact of Gene Dosage on Gene Expression, Biological Processes and Survival in Cervical Cancer: A Genome-Wide Follow-Up Study |
title_sort | impact of gene dosage on gene expression, biological processes and survival in cervical cancer: a genome-wide follow-up study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039463/ https://www.ncbi.nlm.nih.gov/pubmed/24879114 http://dx.doi.org/10.1371/journal.pone.0097842 |
work_keys_str_mv | AT medinamartinezingrid impactofgenedosageongeneexpressionbiologicalprocessesandsurvivalincervicalcanceragenomewidefollowupstudy AT barronvaleria impactofgenedosageongeneexpressionbiologicalprocessesandsurvivalincervicalcanceragenomewidefollowupstudy AT romanbassaureedgar impactofgenedosageongeneexpressionbiologicalprocessesandsurvivalincervicalcanceragenomewidefollowupstudy AT juareztorreseligia impactofgenedosageongeneexpressionbiologicalprocessesandsurvivalincervicalcanceragenomewidefollowupstudy AT guardadoestradamariano impactofgenedosageongeneexpressionbiologicalprocessesandsurvivalincervicalcanceragenomewidefollowupstudy AT espinosaanamaria impactofgenedosageongeneexpressionbiologicalprocessesandsurvivalincervicalcanceragenomewidefollowupstudy AT bermudezmiriam impactofgenedosageongeneexpressionbiologicalprocessesandsurvivalincervicalcanceragenomewidefollowupstudy AT fernandezfernando impactofgenedosageongeneexpressionbiologicalprocessesandsurvivalincervicalcanceragenomewidefollowupstudy AT venegasvegacarlos impactofgenedosageongeneexpressionbiologicalprocessesandsurvivalincervicalcanceragenomewidefollowupstudy AT orozcolorena impactofgenedosageongeneexpressionbiologicalprocessesandsurvivalincervicalcanceragenomewidefollowupstudy AT zentenoedgar impactofgenedosageongeneexpressionbiologicalprocessesandsurvivalincervicalcanceragenomewidefollowupstudy AT kofmansusana impactofgenedosageongeneexpressionbiologicalprocessesandsurvivalincervicalcanceragenomewidefollowupstudy AT berumenjaime impactofgenedosageongeneexpressionbiologicalprocessesandsurvivalincervicalcanceragenomewidefollowupstudy |